and Wegovy, says the company is investing over $6 billion dollars to help meet the increased demand for the drugs amid
Novo Nordisk told ABC News that despite the shortages for Wegovy, the company has enough product on the market to start 25,000 patients on Wegovy per week -- a fourfold increase since late last year. Without insurance coverage, the out-of-pocket cost for medications like Ozempic and Wegovy can run as high as $1,000 or more per month.
Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder: